Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared a post on X:
“Always a pleasure to listen to Gregory Riely from Memorial Sloan Kettering Cancer Center discussing emerging therapies in lung cancer targeting TP53, MTAP deletion, SMARC4 alterations.”
More posts featuring Estela Rodriguez.
